Open Access. Powered by Scholars. Published by Universities.®
Nanoscience and Nanotechnology Commons™
Open Access. Powered by Scholars. Published by Universities.®
- Discipline
Articles 1 - 2 of 2
Full-Text Articles in Nanoscience and Nanotechnology
Investigating The Novel Role Of Dextromethorphan In Mitigating Oxidative Stress Induced Changes In Retinal Pigment Epithelial Cells (Rpe), Zeinab A. Mohamed
Investigating The Novel Role Of Dextromethorphan In Mitigating Oxidative Stress Induced Changes In Retinal Pigment Epithelial Cells (Rpe), Zeinab A. Mohamed
USF Tampa Graduate Theses and Dissertations
Oxidative stress contributes to the degeneration of retinal pigment epithelial (RPE) cells and photoreceptors that lead to the dry form of age-related macular degeneration. Activation of N-Methyl-D-aspartate (NMDA) receptors contributes to the increase of free radicals that induce oxidative stress-induced changes. Our study investigates if Dextromethorphan, an NMDA receptor antagonist, reverses oxidative stress-induced changes in RPE. We used Paraquat and H2O2 as oxidative stress-inducing agents to induce oxidative damage in human ARPE-19 cells. To illustrate the change in cell viability and measure the apoptosis of ARPE-19 cells from oxidative damage, we performed MTT assay and Annexin V-DAPI flow cytometry analysis. …
Testing Glutathione-S-Transferase Mu 1 (Gstm1) In Protecting Retinal Pigment Epithelium Cells From Oxidative Stress, Inyoung C. Garner
Testing Glutathione-S-Transferase Mu 1 (Gstm1) In Protecting Retinal Pigment Epithelium Cells From Oxidative Stress, Inyoung C. Garner
USF Tampa Graduate Theses and Dissertations
Currently, the most widely available treatment for wet age-related macular degeneration (AMD) involves the intraocular delivery of biopharmaceuticals, such as anti-VEGF therapy. Drawbacks of this treatment includes a short-term efficacy, requiring repeated injections with additional risks, and a limited availability of options for non-responders. Furthermore, there are no treatments available for patients diagnosed with dry-AMD. The drawbacks and limitations of current therapies represent a need for more effective and permanent therapy as the prevalence of the population affected by AMD is growing. Antioxidant gene therapies are one solution to these implications, protecting the cells from oxidative stress which is one …